Literature DB >> 17992279

Gold(I) chloride adducts of 1,3-bis(di-2-pyridylphosphino)propane: synthesis, structural studies and antitumour activity.

Anthony S Humphreys1, Aleksandra Filipovska, Susan J Berners-Price, George A Koutsantonis, Brian W Skelton, Allan H White.   

Abstract

The novel water soluble bidentate phosphine ligand 1,3-bis(di-2-pyridylphosphino)propane (d2pypp) has been synthesized by a convenient route involving treatment of 2-pyridyllithium with Cl(2)P(CH(2))(3)PCl(2) and isolation in crystalline form as the hydrochloride salt. The synthesis of the precursor Cl(2)P(CH(2))(3)PCl(2) has been optimized by the use of triphosgene as the chlorinating agent. The 2 : 1 and 1 : 2 AuCl : d2pypp adducts have been synthesized and characterized by NMR spectroscopy and single crystal X-ray studies, and shown to be of the form (AuCl)(2)(mu-d2pypp-P,P') and [Au(d2pypp-P,P')(2)]Cl(.3.75H(2)O), respectively. The latter is more lipophilic than analogous 1 : 2 adducts of gold(I) chloride with the diphosphine ligands 1,2-bis(di-n-pyridylphosphino)ethane (dnpype) for n = 2, 3 and 4, based on measurement of the n-octanol-water partition coefficient (log P = -0.46). A single crystal structure determination of the 1 : 2 Au(I) complex of the 3-pyridyl ethane ligand shows it to be of the form [Au(d3pype-P,P')(2)]Cl.5H(2)O. The in vitro cytotoxic activity of [Au(d2pypp)(2)]Cl was assessed in human normal and cancer breast cells and selective toxicity to the cancer cells found. The significance of these results to the antitumour properties of chelated 1 : 2 Au(I) diphosphine complexes is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17992279     DOI: 10.1039/b705008a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  12 in total

1.  Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine.

Authors:  Zhen-Feng Chen; Yan-Cheng Liu; Yan Peng; Xue Hong; Hong-Hong Wang; Min-Min Zhang; Hong Liang
Journal:  J Biol Inorg Chem       Date:  2011-09-30       Impact factor: 3.358

2.  Water Soluble Phosphane-Gold(I) Complexes. Applications as Recyclable Catalysts in a Three-component Coupling Reaction and as Antimicrobial and Anticancer Agents.

Authors:  Benelita T Elie; Chaya Levine; Iban Ubarretxena-Belandia; Armando Varela-Ramírez; Renato J Aguilera; Rafael Ovalle; María Contel
Journal:  Eur J Inorg Chem       Date:  2009-06-30       Impact factor: 2.524

3.  The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy.

Authors:  Vesna Milacic; Q Ping Dou
Journal:  Coord Chem Rev       Date:  2009       Impact factor: 22.315

4.  Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes.

Authors:  C Ceresa; G Nicolini; S Semperboni; V Gandin; M Monfrini; F Avezza; P Alberti; A Bravin; M Pellei; C Santini; Guido Cavaletti
Journal:  Neurotox Res       Date:  2018-01-17       Impact factor: 3.911

Review 5.  Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer.

Authors:  Nazia Nayeem; Maria Contel
Journal:  Chemistry       Date:  2021-05-05       Impact factor: 5.020

Review 6.  Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin.

Authors:  Sarah Spreckelmeyer; Chris Orvig; Angela Casini
Journal:  Molecules       Date:  2014-09-29       Impact factor: 4.411

7.  Gold-containing compound BDG-I inhibits the growth of A549 lung cancer cells through the deregulation of miRNA expression.

Authors:  Ali Alhoshani; A Alrashdi; Khaled Alhosaini; Fawaz E Alanazi; Nehad M Alajez; Muhammad Altaf; Anvarhusein A Isab; Hesham M Korashy
Journal:  Saudi Pharm J       Date:  2018-06-06       Impact factor: 4.330

Review 8.  The gold complex auranofin: new perspectives for cancer therapy.

Authors:  Farah H Abdalbari; Carlos M Telleria
Journal:  Discov Oncol       Date:  2021-10-20

Review 9.  Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?

Authors:  Chien Ing Yeo; Kah Kooi Ooi; Edward R T Tiekink
Journal:  Molecules       Date:  2018-06-11       Impact factor: 4.411

Review 10.  Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules.

Authors:  Rossana Galassi; Lorenzo Luciani; Junbiao Wang; Silvia Vincenzetti; Lishan Cui; Augusto Amici; Stefania Pucciarelli; Cristina Marchini
Journal:  Biomolecules       Date:  2022-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.